These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31604954)

  • 21. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
    Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
    Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical Validation of the Glyoxylate Cycle in the Cyanobacterium Chlorogloeopsis fritschii Strain PCC 9212.
    Zhang S; Bryant DA
    J Biol Chem; 2015 May; 290(22):14019-30. PubMed ID: 25869135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
    Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
    J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-range effects in anion-π interactions: their crucial role in the inhibition mechanism of Mycobacterium tuberculosis malate synthase.
    Bauzá A; Quiñonero D; Deyà PM; Frontera A
    Chemistry; 2014 Jun; 20(23):6985-90. PubMed ID: 24740694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
    Quartararo CE; Hadi T; Cahill SM; Blanchard JS
    Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the
    Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
    J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rheostat mechanism governs the bifurcation of carbon flux in mycobacteria.
    Murima P; Zimmermann M; Chopra T; Pojer F; Fonti G; Dal Peraro M; Alonso S; Sauer U; Pethe K; McKinney JD
    Nat Commun; 2016 Aug; 7():12527. PubMed ID: 27555519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylcitrate cycle activation during adaptation of Fusarium solani and Fusarium verticillioides to propionyl-CoA-generating carbon sources.
    Domin N; Wilson D; Brock M
    Microbiology (Reading); 2009 Dec; 155(Pt 12):3903-3912. PubMed ID: 19661181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
    Nandakumar M; Nathan C; Rhee KY
    Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from
    Antil M; Gupta V
    Protein Pept Lett; 2022; 29(12):1031-1041. PubMed ID: 36201276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
    Krátký M; Vinšová J
    Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis.
    Shukla H; Khan SR; Shukla R; Krishnan MY; Akhtar MS; Tripathi T
    Tuberculosis (Edinb); 2018 Jul; 111():161-169. PubMed ID: 30029903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of acyl coenzyme A carboxylases from Mycobacterium tuberculosis and Mycobacterium bovis, which produce multiple methyl-branched mycocerosic acids.
    Rainwater DL; Kolattukudy PE
    J Bacteriol; 1982 Aug; 151(2):905-11. PubMed ID: 6807964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central metabolism in Mycobacterium smegmatis during the transition from O2-rich to O2-poor conditions as studied by isotopomer-assisted metabolite analysis.
    Tang YJ; Shui W; Myers S; Feng X; Bertozzi C; Keasling JD
    Biotechnol Lett; 2009 Aug; 31(8):1233-40. PubMed ID: 19357814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
    Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
    J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of acetate metabolism in Corynebacterium glutamicum: transcriptional control of the isocitrate lyase and malate synthase genes.
    Wendisch VF; Spies M; Reinscheid DJ; Schnicke S; Sahm H; Eikmanns BJ
    Arch Microbiol; 1997 Oct; 168(4):262-9. PubMed ID: 9297462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a bifunctional glyoxylate cycle enzyme, malate synthase/isocitrate lyase, of Euglena gracilis.
    Nakazawa M; Nishimura M; Inoue K; Ueda M; Inui H; Nakano Y; Miyatake K
    J Eukaryot Microbiol; 2011; 58(2):128-33. PubMed ID: 21332878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase.
    Shukla H; Kumar V; Singh AK; Singh N; Kashif M; Siddiqi MI; Yasoda Krishnan M; Sohail Akhtar M
    Biochimie; 2015 Mar; 110():73-80. PubMed ID: 25576828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
    Shukla R; Shukla H; Tripathi T
    Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.